CRVS
Corvus Pharmacet (CRVS)
NASDAQ
$11.46+$0.09 (+0.78%)
Price as of Nov 11, 2026 7:30 PM EST
  • $959.1M
    Market Cap
  • 39.17%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 25
Valuation
CRVS
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 25
Valuation
CRVS
vs History
vs S&P 500
3-Month Momentum
-26.86%
12-Month Momentum
27.05%
3-Month Risk Adjusted Momentum
-123.67%
12-Month Risk Adjusted Momentum
15.22%

True Yield

N/A
Valuation
CRVS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 35
Valuation
CRVS
vs History
vs S&P 500
Ohlson's O-Score
1